Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-00-055008
Filing Date
2000-12-28
Accepted
2000-12-28 00:00:00
Documents
7
Period of Report
2000-09-30

Document Format Files

Seq Description Document Type Size
1 10-K a2033633z10-k.htm 10-K 193622
2 EXHIBIT 10.32 a2033633zex-10_32.htm EX-10.32 150332
3 EXHIBIT 10.34 a2033633zex-10_34.htm EX-10.34 49135
4 EXHIBIT 10.35 a2033633zex-10_35.htm EX-10.35 11894
5 EXHIBIT 13.1 a2033633zex-13_1.htm EX-13.1 450515
6 EXHIBIT 23.1 a2033633zex-23_1.htm EX-23.1 2306
7 EXHIBIT 27 a2033633zex-27.txt EX-27 2280
  Complete submission text file 0000912057-00-055008.txt   862299
Mailing Address 8899 UNIVERSITY CENTER LANE STE 400 SAN DIEGO CA 92122
Business Address 8899 UNIVERSITY CTR LANE STE 400 SAN DIEGO CA 92122 8584534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-14430 | Film No.: 797620
SIC: 2833 Medicinal Chemicals & Botanical Products